Watch for Errors With Newer Insulins

Errors with newer insulins are bringing insulin safety to the forefront again.

More patients are switching products as new insulins become available. For instance, patients may switch to a more affordable biosimilar or a more convenient longer-acting formulation.

But this also brings up new opportunities for errors.


Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote